SEC Form 4/A · accession 0001273636-18-000042
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Ivana Magovcevic
Director
Period of report
Jul 25, 2018
Accepted (ET)
Jul 30, 2018 · 9:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $4.25 | Jul 25, 2018 | A | 10,000 | A | — | Jul 25, 2028 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This Form 4 is being amended to correct a scrivener's error with regards to the number of shares underlying the option grant.
- F2The option becomes exercisable on July 25, 2019.